Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Kushal Kandhari

Concepts (76)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Corneal Injuries
4
2024
42
1.330
Why?
Arsenicals
1
2023
28
0.780
Why?
Mustard Gas
4
2025
77
0.760
Why?
Chemical Warfare Agents
4
2025
89
0.750
Why?
Rabbits
5
2025
651
0.370
Why?
Dexamethasone
4
2025
368
0.310
Why?
Breast Neoplasms
1
2023
2418
0.300
Why?
Irritants
2
2024
42
0.240
Why?
Procollagen-Proline Dioxygenase
1
2026
27
0.240
Why?
Collagen Type I
1
2026
144
0.220
Why?
Smoke
1
2026
149
0.220
Why?
Limbus Corneae
1
2025
8
0.220
Why?
Apoptosis
2
2024
2439
0.210
Why?
Cigarette Smoking
1
2026
103
0.210
Why?
G2 Phase Cell Cycle Checkpoints
1
2024
43
0.210
Why?
Cyclin-Dependent Kinase Inhibitor p27
1
2024
64
0.210
Why?
Flavonols
1
2024
27
0.200
Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2024
104
0.200
Why?
Flavonoids
1
2024
85
0.200
Why?
Matrix Metalloproteinases
1
2024
95
0.200
Why?
Unfolded Protein Response
1
2023
58
0.200
Why?
Collagen
1
2026
460
0.190
Why?
Receptor-Interacting Protein Serine-Threonine Kinases
1
2023
13
0.190
Why?
Flavones
1
2023
11
0.190
Why?
Protein Processing, Post-Translational
1
2026
487
0.190
Why?
Acetylcysteine
1
2023
139
0.190
Why?
Nuclear Pore Complex Proteins
1
2023
40
0.190
Why?
Neoplastic Stem Cells
1
2026
403
0.180
Why?
Epithelial-Mesenchymal Transition
1
2024
219
0.180
Why?
Cell Death
1
2023
379
0.170
Why?
Anti-Inflammatory Agents
1
2025
474
0.170
Why?
Xenograft Model Antitumor Assays
1
2024
930
0.160
Why?
MAP Kinase Signaling System
1
2023
307
0.160
Why?
Stem Cells
1
2025
613
0.160
Why?
Oxidative Stress
2
2025
1369
0.160
Why?
Antioxidants
1
2023
544
0.150
Why?
Reactive Oxygen Species
1
2023
610
0.150
Why?
RNA-Binding Proteins
1
2023
465
0.140
Why?
Animals
10
2026
38107
0.140
Why?
Cell Line, Tumor
2
2024
3545
0.140
Why?
Cornea
3
2024
156
0.140
Why?
Pulmonary Disease, Chronic Obstructive
1
2024
928
0.120
Why?
Disease Progression
1
2024
2867
0.120
Why?
Adenocarcinoma
1
2022
927
0.110
Why?
Prostatic Neoplasms
1
2022
972
0.110
Why?
Lung Neoplasms
1
2026
2675
0.090
Why?
Humans
8
2026
146342
0.070
Why?
Prolyl Hydroxylases
1
2026
6
0.060
Why?
Hydroxylation
1
2026
47
0.060
Why?
Matrix Metalloproteinase Inhibitors
1
2024
16
0.050
Why?
Mechlorethamine
1
2024
52
0.050
Why?
Caspases
1
2024
233
0.050
Why?
Actin Cytoskeleton
1
2024
97
0.050
Why?
Mice, Nude
1
2024
668
0.050
Why?
Mice
3
2026
18297
0.050
Why?
Transcriptional Regulator ERG
1
2022
14
0.040
Why?
Tumor Microenvironment
1
2026
747
0.040
Why?
Chromatography, Liquid
1
2024
453
0.040
Why?
Ligands
1
2024
678
0.040
Why?
Signal Transduction
2
2026
5246
0.040
Why?
Actins
1
2024
422
0.040
Why?
Serine Endopeptidases
1
2022
129
0.040
Why?
DNA Damage
1
2024
439
0.040
Why?
Prostate
1
2022
159
0.040
Why?
Inflammation Mediators
1
2024
508
0.040
Why?
Tandem Mass Spectrometry
1
2024
576
0.040
Why?
Fibroblasts
1
2026
1034
0.040
Why?
Carcinogenesis
1
2022
226
0.040
Why?
Oncogene Proteins, Fusion
1
2022
213
0.040
Why?
Head and Neck Neoplasms
1
2024
563
0.040
Why?
Mice, Knockout
1
2026
3125
0.040
Why?
Proteomics
1
2024
1203
0.030
Why?
Cell Proliferation
1
2024
2502
0.030
Why?
Female
1
2023
79499
0.030
Why?
Inflammation
1
2025
2919
0.020
Why?
Male
2
2025
73396
0.010
Why?
Kandhari's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)